Could an arthritis drug help fight tough breast cancers?
Disease control
Recruiting now
This study tests whether adding tocilizumab, an anti-inflammatory drug, to standard chemotherapy improves outcomes for people with metastatic triple-negative or ER-low breast cancer. Researchers will compare the combination to chemotherapy alone in 168 Black and non-Black patient…
Phase: PHASE2 • Sponsor: Kathy Miller • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC